Masuku, S., & Barth, S. (2026). Development of recombinant immunotoxins targeting overexpressed cell surface biomarkers trophoblast cell-surface antigen 2 and mesothelin for cervical cancer treatment. Department of Integrative Biomedical Sciences (IBMS).
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Masuku, Sizalobuhle, and Stefan Barth. Development of Recombinant Immunotoxins Targeting Overexpressed Cell Surface Biomarkers Trophoblast Cell-surface Antigen 2 and Mesothelin for Cervical Cancer Treatment. Department of Integrative Biomedical Sciences (IBMS), 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Masuku, Sizalobuhle, and Stefan Barth. Development of Recombinant Immunotoxins Targeting Overexpressed Cell Surface Biomarkers Trophoblast Cell-surface Antigen 2 and Mesothelin for Cervical Cancer Treatment. Department of Integrative Biomedical Sciences (IBMS), 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.